August J. Troendle, 10% Owner, Director, President & CEO, on September 17, 2026, sold 10,880 shares in Medpace Holdings (MEDP) for $6,749,952. Following the Form 4 filing with the SEC, Troendle has control over a total of 5,237,292 common shares of the company, with 504,273 shares held directly and 4,733,019 controlled indirectly.
SEC Filing: